Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ulta Beauty Inc (NQ: ULTA )

377.65 +8.67 (+2.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ulta Beauty Inc

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
31 32 Next >
Market Rally Pulls Back; Walmart, Target, BBBY Stock In Focus: Weekly Review
The stock market rally hit resistance near the 200-day line. Walmart and Target headlined retail earnings. BBBY stock soared and crashed. 
Via Investor's Business Daily
Why This Foot Locker Analyst Is Encouraged By New CEO
Foot Locker, Inc (NYSE: FL) unexpectedly announced the departure of current CEO Richard Johnson and named former Ulta Beauty Inc (NASDAQ: ULTA) CEO Mary Dillon as his replacement, which is 
Via Benzinga
Foot Locker Shares Soar On Q2 EPS Beat, New CEO
Via Benzinga
Ulta Beauty to Report Second Quarter Results on August 25, 2022
From Ulta Beauty, Inc.
Via Business Wire
Ulta Beauty Stock Has Dazzling Record; Can It Continue?
Similarly, Ulta Beauty stock boasts a 91 Composite Rating, putting it in the top 10% of all companies for profit growth. 
Via Investor's Business Daily
Launch of Def Leppard beauty collection creating Hysteria in the makeup industry
MANAHAWKIN, N.J. - June 26, 2022 - PRLog -- Rock and Roll Beauty™ are pleased to announce the release of their Def Leppard limited-edition beauty collection. Def Leppard helped define a true era in... 
Via PRLog
Where Ulta Beauty Stands With Analysts
Analysts have provided the following ratings for Ulta Beauty (NASDAQ:ULTA) within the last quarter: 
Via Benzinga
10 Consumer Discretionary Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Ulta Beauty Launches Digital Innovation Fund, Prisma Ventures
From Ulta Beauty
Via Business Wire
Jessica Alba's Honest Beauty Launches At More Than 635 Ulta Beauty Locations
Via Benzinga
Revlon (REV) Stock Soars on Bankruptcy Victory
The doubling of the price of REV stock still left Revlon with a value of under $500 million and over $3 billion in debt. 
Via InvestorPlace
Warren Buffett Favorite Leads 5 Stocks To Watch Near Buy Points
Occidental Petroleum is eyeing an early entry, but earnings are due Tuesday. 
Via Investor's Business Daily
Dow Jones Giant Amgen Leads 5 Stocks To Watch Near Buy Points
Dow Jones giant Amgen headlines five stocks to watch setting near buy points or key support levels that may offer early entries. 
Via Investor's Business Daily
Retail Innovation: Invest In The Leaders
A lot of retail rotated online in the pandemic, but now that there is a reopening, are shoppers returning to the mall? Is brick and mortar coming back? 
Via Talk Markets
COSRX Launches Second Season of Global Supporters Program
The participants will be looking to take part in bigger, grander events peppered with a bucket load of gifts 
Via Newswire.com
Read How Raymond James Shifts Ratings On Ulta Beauty & Sally Beauty Amid Inflation
Via Benzinga
Milbrook Properties Ltd. Expands Portfolio With 4 New Acquisitions in DE, MD, NJ, and PA
Milbrook Properties is excited the announce the expansion of its portfolio into the Mid-Atlantic area of Maryland, Delaware, and Pennsylvania, including one new acquisition in North Jersey totaling... 
Via Newswire.com
What Companies Will Pay for Abortion Travel?
Several companies are offering to pay for their employees' travel expenses when seeking an abortion after the Supreme Court's recent ruling. 
Via InvestorPlace
Ulta Beauty's Return On Capital Employed Overview
According to Benzinga Pro, during Q1, Ulta Beauty (NASDAQ:ULTA) earned $331.39 million, a 14.52% increase from the preceding quarter. Ulta Beauty's sales decreased to $2.35 billion, a 14.03% change... 
Via Benzinga
Expert Ratings for Ulta Beauty
Over the past 3 months, 14 analysts have published their opinion on Ulta Beauty (NASDAQ:ULTA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022
Upgrades 
Via Benzinga
Ulta Beauty Earns Membership In 95-Plus Composite Rating Club
Earnings growth for highly ranked beauty goods retailer Ulta Beauty the past four quarters ranged from 54% to a stunning 519%. 
Via Investor's Business Daily
7 Nasdaq Stocks to Buy for Double-Digit Gains
These are the best Nasdaq stocks to buy for double-digit gains. AVGO, CSGP, COST, ENPH, PEP, TTD and ULTA can make great investments. 
Via InvestorPlace
Ulta Beauty Launches MUSE Accelerator Program Focused on Early-Stage BIPOC Brands
From Ulta Beauty
Via Business Wire
Leverage Relative Price Strength With These 5 Top Stocks
Continuing the trend since the start of this year, the month of May turned out tumultuous for Wall Street, bringing wild market action and volatility. 
Via Talk Markets
5 Stocks in S&P 500 ETF That Led the Rally Last Week
While most of the stocks in SPY’s portfolio have risen, here are five stocks from various corners of the market that have gained in double digits last week. 
Via Talk Markets
70 Biggest Movers From Friday
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... 
Via Benzinga
Ulta Beauty to Participate in Upcoming Investor Conferences
From Ulta Beauty, Inc.
Via Business Wire
Market Rally Confirmed As Macy's, Dollar Tree Lead Retail Revival, Albemarle, Broadcom In Focus: Weekly Review
The market rally is a confirmed uptrend, as Macy's, Dollar Tree and Albemarle soared this week. 
Via Investor's Business Daily
Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today?
Iovance Therapeutics (IOVA) stock is falling hard on Friday following the release of clinical trial data for its melanoma treatment. 
Via InvestorPlace
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.